Viewing Study NCT02394834

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-06-24 @ 10:17 AM
Study NCT ID: NCT02394834
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-09
First Post: 2015-03-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Sponsor: Takeda
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab View